# Bio Essence Corp > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Bio Essence Corp). ## Overview Bio Essence Corp is a California-based holding company whose operating history has centered on health supplements and OEM manufacturing/distribution services. The business was reorganized over time through subsidiaries, with manufacturing and distribution previously housed in BEP and BEH, and a dormant prescription-medicine R&D subsidiary, McBE, later dissolved. Following the disposal of its manufacturing subsidiary, the company now relies mainly on outsourced OEM service activity and supplement sales rather than in-house production. Recent filings show a business in transition, with management emphasizing OEM services as the core revenue driver and a source of better gross margins. ## Products & services • Health supplement product sales • OEM / manufacturing service revenue • Product shipping and delivery income • Outsourced production support • Sales and promotion of supplement products - **OEM / manufacturing services** (85%) — Contract manufacturing and OEM services provided to customers that need outsourced production support. - **Health supplement products** (10%) — Branded or distributed health supplement products sold directly or through customers. - **Shipping and delivery income** (5%) — Ancillary logistics and delivery charges billed in connection with product shipments. - Health supplement product sales - OEM / manufacturing service revenue - Product shipping and delivery income - Outsourced production support - Sales and promotion of supplement products ## Customers Bio Essence sells primarily to customers that source health supplements or outsource manufacturing work, rather than to end consumers directly. The filings indicate a major OEM customer, Qnet Limited, which contributed to the recent increase in service revenue. Customers buy from the company because it can provide outsourced production capacity and supplement-related supply support without requiring them to maintain their own manufacturing footprint. The company also serves buyers of health supplement products, likely including distributors and commercial resellers that value a ready-made supply relationship. As the business has shifted away from owned manufacturing, customer relationships tied to outsourced OEM execution have become more important than pure product sales. - **OEM service customers** (primary) — Buy outsourced manufacturing and production support, mainly to avoid building their own facilities and to scale orders quickly. - **Health supplement product buyers** (secondary) — Purchase finished supplement products for resale or distribution, typically where product sourcing and packaging matter. - **Logistics and shipping customers** (emerging) — Pay for shipping and delivery income associated with product movement and fulfillment. - OEM customers that outsource manufacturing and want contract production capacity - Supplement distributors and resellers that buy finished health products - Commercial buyers seeking shipping and delivery support tied to orders - New customers such as Qnet Limited that can quickly scale service revenue - Customers that value lower fixed-cost sourcing after Bio Essence outsourced production ## Geography The company is incorporated in California and operates from the United States, with its functional currency reported as U.S. dollars. The filings do not provide a country-by-country revenue split, so the geographic profile cannot be quantified from the available excerpts. Operationally, the business has been centered on California subsidiaries and U.S.-based corporate structure, including prior manufacturing and distribution entities. Because the company now outsources manufacturing/OEM work, its geographic exposure is less about owned plants and more about where customers and third-party service providers are located. The lack of disclosed international revenue detail limits visibility into cross-border demand or supply-chain concentration. - United States is the core operating base and reporting currency is USD - California is the main corporate and subsidiary footprint in the filings - No country-level revenue disclosure was provided in the excerpts - Outsourced OEM model reduces dependence on owned manufacturing locations - Geographic exposure is mainly tied to customer demand and third-party suppliers ## Strategy Management is trying to reposition the business around OEM service revenue, which the filings say carries a higher gross profit percentage than product sales. The company is also trying to rebuild growth by strengthening the sales force, offering sales incentives, and increasing marketing and promotion activity. Because the business has accumulated losses and raised going-concern doubts, capital raising is part of the strategy alongside operating improvement. The recent shift away from owned manufacturing toward outsourced OEM execution suggests a lighter-asset model intended to support revenue growth without rebuilding the prior production base. Success depends on winning larger service orders, retaining customers, and securing additional funding to support operations. - **Grow OEM service revenue** (short-term) — OEM services are now the main revenue engine and appear to generate better gross margins than product sales. - **Expand sales and marketing execution** (short-term) — Management believes stronger selling efforts and promotions are needed to rebuild revenue and customer acquisition. - **Secure additional financing** (short-term) — The company has substantial accumulated deficits and disclosed going-concern uncertainty, so liquidity support is essential. - Increase OEM service revenue rather than relying on lower-margin product sales - Expand sales force and incentive programs to win more customer orders - Raise marketing and promotion activity to support demand generation - Use an outsourced production model after disposing of owned manufacturing assets - Seek additional financing through private/public offerings or loans - Improve gross margin mix by emphasizing service revenue ## Risks The most immediate company-specific risk is going-concern uncertainty, driven by recurring losses and a large accumulated deficit. Revenue is concentrated in OEM service activity, so the business is exposed to customer order volatility, customer concentration, and the loss or delay of large contracts. Because the company now outsources manufacturing, it also depends on third parties for execution quality, timing, and cost control, which can pressure margins and service reliability. More broadly, supplement and contract manufacturing businesses face regulatory, quality, and demand risks, including changing consumer preferences and competition from larger, better-capitalized operators. Financing risk is also material because the company may need external capital to sustain operations and fund growth initiatives. - **Going-concern uncertainty** [critical] — The company disclosed substantial doubt about its ability to continue as a going concern due to losses and accumulated deficit. - **Customer concentration in OEM services** [high] — Recent revenue growth was driven by a major order from a new customer, which can create dependence on a small number of accounts. - **Outsourced manufacturing dependency** [high] — After disposing of BEP, the company no longer controls its own manufacturing and must rely on third parties for OEM execution. - **Financing and dilution risk** [high] — Management expects to raise funds through private/public offerings or loans, which may be difficult or dilutive. - Going-concern risk from recurring losses and accumulated deficit - Customer concentration risk in OEM services, including dependence on large orders - Third-party manufacturing and outsourcing risk after disposal of owned production assets - Margin pressure if service mix, pricing, or fulfillment costs move unfavorably - Regulatory and quality-control risk in health supplement and manufacturing activities - Financing risk if private/public capital or bank loans are not available on acceptable terms ## Accounting Revenue is recognized under ASC 606 at a point in time, typically upon delivery, which makes shipment timing important for quarterly results. The company also records product revenue reserves for discounts, returns, and rebates, so reported sales can differ from gross invoiced amounts and require judgment. Accounts receivable is monitored for credit losses, but the company reported no bad debt allowance in the periods cited, which means future customer stress could change earnings quickly if reserves become necessary. Because the business has a mix of product sales, OEM service revenue, and shipping income, quarterly comparisons can be volatile as the mix shifts toward higher-margin service work. The going-concern disclosure and use of estimates also matter because liquidity pressure can affect assumptions around collectability, reserves, and the ability to continue operations. - **ASC 606 revenue recognition** — Quarterly revenue volatility - **Revenue reserves for discounts, returns, and rebates** — Net revenue and receivables - **Accounts receivable allowance** — Earnings and balance sheet valuation - **Going-concern disclosure** — Financial statement interpretation - Point-in-time revenue recognition affects when OEM and product sales appear in results - Discount, return, and rebate reserves reduce reported product revenue - Accounts receivable collectability judgments affect credit loss expense and net receivables - Revenue mix shifts between product sales and OEM services can change gross margin quarter to quarter - Going-concern assessment influences disclosure and investor interpretation of reported numbers - Discontinued operations from sold/dissolved subsidiaries affect comparability across periods --- *Last updated: 2026-08-11T04:46:23.719118+00:00*